nLife Therapeutics, S.L. Product Trends & Analysis - 2015

1
nLife Therapeutics, S.L. Product Pipeline Review
- 2015
No. Pages 26
Published on October - 2015
2
.
Report Overview
About nLife Therapeutics, S.L. Product Pipeline
Review 2015 Global Markets Directs, nLife
Therapeutics, S.L. Product Pipeline Review -
2015, provides an overview of the nLife
Therapeutics, S.L.s pharmaceutical research and
development focus. This report provides
comprehensive information on the current
therapeutic developmental pipeline of nLife
Therapeutics, S.L.s, complete with comparative
analysis at various stages, therapeutics
assessment by drug target, mechanism of action
(MoA), route of administration (RoA) and molecule
type. It also reviews latest updates, and
featured news and press releases, along with
special features on late-stage and discontinued
projects. Global Markets Directs report features
investigational drugs from across globe covering
over 20 therapy areas and nearly 3,000
indications. The report is built using data and
information sourced from Global Markets Directs
proprietary databases, Company/University
websites, SEC filings, investor presentations and
featured press releases from company/university
sites and industry-specific third party sources,
put together by Global Markets Directs team. Get
Full Details On http//www.researchbeam.com/nlif
e-therapeutics-sl-product-pipeline-review-2015-mar
ket
3
.
Report Overview
Drug profiles/records featured in the report
undergoes periodic updation following a stringent
set of processes that ensures that all the
profiles are updated with the latest set of
information. Additionally, processes including
live news deals tracking, browser based
alert-box and clinical trials registries tracking
ensure that the most recent developments are
captured on a real time basis. The report
enhances decision making capabilities and help to
create effective counter strategies to gain
competitive advantage. It strengthens RD
pipelines by identifying new targets and MOAs to
produce first-in-class and best-in-class
products. Note Certain sections in the report
may be removed or altered based on the
availability and relevance of data for the
indicated disease. Scope The report provides
brief overview of nLife Therapeutics, S.L.
including business description, key information
and facts, and its locations and subsidiaries The
report reviews current pipeline of nLife
Therapeutics, S.L.s human therapeutic division
and enlists all their major and minor projects
4
.
Report Overview
The report features product description and
descriptive mechanism of action for key pipeline
products along with the products developmental
history and major milestones Special feature on
out-licensed and partnered product portfolio The
report summarizes all the dormant and
discontinued pipeline projects Latest company
statement Latest news and deals relating to the
nLife Therapeutics, S.L.s pipeline
products   Reasons to buy Evaluate nLife
Therapeutics, S.L.s strategic position with total
access to detailed information on its product
pipeline Assess the growth potential of nLife
Therapeutics, S.L. in its therapy areas of
focus Identify new drug targets and therapeutic
classes in the nLife Therapeutics, S.L.s RD
portfolio and develop key strategic initiatives
to reinforce pipeline in those areas Exploit
in-licensing opportunities by identifying windows
of opportunity to fill portfolio gaps
5
Report Overview

• Develop strategic initiatives by understanding
  the focus areas of nLife Therapeutics, S.L. and
  exploit collaboration and partnership
  opportunities
• Identify emerging players with potentially strong
  product portfolio and create effective
  counter-strategies to gain competitive advantage
• Plan mergers and acquisitions effectively by
  identifying the most promising pipeline of nLife
  Therapeutics, S.L.
• Develop and design in-licensing and out-licensing
  strategies by identifying prospective partners
  with the most attractive projects to enhance and
  expand business potential and Scope
• Explore the dormant and discontinued projects of
  nLife Therapeutics, S.L. and identify potential
  opportunities in those areas
• Avoid Intellectual Property Rights related issues

6
Table Of Contents
List of Tables 4List of Figures 4nLife
Therapeutics, S.L. Snapshot 5nLife Therapeutics,
S.L. Overview 5Key Information 5Key Facts
5nLife Therapeutics, S.L. - Research and
Development Overview 6Key Therapeutic Areas
6nLife Therapeutics, S.L. - Pipeline Review
8Pipeline Products by Stage of Development
8Pipeline Products - Monotherapy 9nLife
Therapeutics, S.L. - Pipeline Products Glance
10nLife Therapeutics, S.L. - Early Stage
Pipeline Products 10Preclinical
Products/Combination Treatment Modalities 10
7
Table Of Contents
Discovery Products/Combination Treatment
Modalities 11nLife Therapeutics, S.L. - Drug
Profiles 12 NLF-MO 12Product Description
12Mechanism of Action 12RD Progress 12NLF-NEU
13Product Description 13Mechanism of Action
13RD Progress 13NLFPD-1233 14Product
Description 14Mechanism of Action 14RD
Progress 14
8
Table Of Contents
OL-1 15Product Description 15Mechanism of
Action 15RD Progress 15Antisense
Oligonucleotide to Activate Dystrophin for
Duchene Muscular Dystrophy 16Product Description
16Mechanism of Action 16RD Progress
16 Enquiry about this report _at_
http//www.researchbeam.com/nlife-therapeutics-sl-
product-pipeline-review-2015-market/enquire-about-
report
9
FOR MORE DETAILS
Visit us at
http//www.researchbeam.com/nlife-therapeutics-sl-
product-pipeline-review-2015-market
Stay With Us
5933 NE Win Sivers Drive,205, Portland, OR
97220United States
TELEPHONE [phone] E-MAIL
sales_at_researchbeam.com